Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study

BACKGROUND: This multicenter, open-label, prospective, single cohort study evaluated the effectiveness and safety of adalimumab in a clinical setting reflecting the Canadian standard of care for the treatment of patients with rheumatoid arthritis (RA). METHODS: Patients ≥ 18 years of age with a hist...

Descripción completa

Detalles Bibliográficos
Autores principales: Haraoui, Boulos, Cividino, Alfred, Stewart, Jacqueline, Guérette, Benoît, Keystone, Edward C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226526/
https://www.ncbi.nlm.nih.gov/pubmed/22093579
http://dx.doi.org/10.1186/1471-2474-12-261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226526/
https://www.ncbi.nlm.nih.gov/pubmed/22093579
http://dx.doi.org/10.1186/1471-2474-12-261

Ejemplares similares